Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care

scientific article published on 2 June 2010

Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1093/EURHEARTJ/EHQ163
P698PubMed publication ID20519241
P5875ResearchGate publication ID44645830

P50authorJames JanuzziQ63144011
Rob DoughtyQ88239527
Roxy SeniorQ91296565
Mark RichardsQ105243769
Jens T RosenbergQ108645281
P2093author name stringFinn Gustafsson
Paul O Collinson
Per Hildebrandt
David C Gaze
Ahmet Fuat
P2860cites workBias in meta-analysis detected by a simple, graphical testQ24685585
Meta-analysis in clinical trialsQ27860779
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analysesQ27860840
The effects of medications on circulating levels of cardiac natriuretic peptidesQ28212913
The meaning and use of the area under a receiver operating characteristic (ROC) curveQ29547182
A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunctionQ34351391
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of CardiologyQ34830023
The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.Q35581313
Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trialQ35594969
Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failureQ35603212
Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patientsQ37075374
Amino-terminal pro-B-type natriuretic peptide testing in renal diseaseQ37075417
Understanding amino-terminal pro-B-type natriuretic peptide in obesityQ37075421
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunctionQ37108057
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of CardiologyQ40224176
N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosisQ40528931
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.Q44220082
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialQ45069603
Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysersQ45180221
N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoeaQ47973118
Brain natriuretic peptide is elevated in outpatients with atrial fibrillationQ48160360
Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failureQ48495727
Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrationsQ48591524
The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspectiveQ48593408
The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurementsQ48805576
Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failureQ48860105
The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide studyQ48881656
What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?Q53617945
P433issue15
P921main subjectsystoleQ496359
P304page(s)1881-1889
P577publication date2010-06-02
P1433published inEuropean Heart JournalQ2286839
P1476titleAge-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care
P478volume31

Reverse relations

cites work (P2860)
Q36449881Biochemical markers of aging for longitudinal studies in humans
Q44566168Brain natriuretic peptide-guided management of chronic heart failure: first do no harm
Q95660687Cardiac natriuretic peptides
Q37691417Cardiovascular biomarkers and their utility in the older adult
Q36267492Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood
Q37356354Diagnostic rules and algorithms for the diagnosis of non-acute heart failure in patients 80 years of age and older: a diagnostic accuracy and validation study
Q38518602Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer.
Q55346961Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?
Q92925812Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
Q38148978Heart failure in very old adults
Q37107428High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for 'late effects' screening and preventive strategies.
Q35058920Higher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension
Q40715674Impact of using different guideline recommended serum natriuretic peptide thresholds on the diagnosis and referral rates of a diagnostic heart failure clinic.
Q41548532Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
Q49022172Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?
Q45247270Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors
Q46948868Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study
Q35244261NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy
Q34306307NT-ProBNP independently predicts long-term mortality in patients admitted for coronary angiography
Q42230262NT-proBNP and diastolic left ventricular function in patients with Marfan syndrome
Q64233573Natriuretic Peptides in Chronic Heart Failure
Q34614873Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials
Q27027081Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure
Q38223600Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review
Q47687008Point-of-care testing in primary care patients with acute cardiopulmonary symptoms: a systematic review
Q34492442Prevalence and treatment of heart failure in Swedish nursing homes
Q40165610Prognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction
Q41140893Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study
Q61307046Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care
Q41875333Ultra-Sensitive NT-proBNP Quantification for Early Detection of Risk Factors Leading to Heart Failure.
Q34304083Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.

Search more.